Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 54
Filtrar
1.
Bull Exp Biol Med ; 176(1): 82-86, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-38091144

RESUMEN

We studied the effects of single and combined action of protons and carbon ions 12C6+ on the pool of MCF-7 human breast cancer stem cells. Single irradiation with a beam of protons or carbon ions had no significant effects on the relative number of cancer stem cells (CSC). The effects of combined irradiation in a total equieffective dose of 4 Gy depended on the sequence of exposure to ionizing radiations: the relative number of CSC did not change after irradiation with carbon ions and then with protons, but increased in the case of the reverse sequence. The most favorable result, i.e. a decrease in the CSC pool, was observed in the case of sequential irradiation with carbon ions and protons and their equal contribution to total equieffective dose. In this case, the absolute number of CSC decreased by on average 2.1 times in comparison with the control (p<0.05). The revealed regularities are of interest for the further development of new methods of radiation therapy.


Asunto(s)
Neoplasias de la Mama , Protones , Humanos , Femenino , Células MCF-7 , Neoplasias de la Mama/radioterapia , Iones , Carbono , Células Madre Neoplásicas/efectos de la radiación
2.
Bull Exp Biol Med ; 173(6): 749-753, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-36329332

RESUMEN

Radiation response of cancer stem cells was studied in two breast cancer cell lines: luminal A (MCF-7) and triple negative (MDA-MB-231) subtypes. The relative number of CD44+CD24-/low cancer stem cells of the MCF-7 line increased by 1.7 times under the influence of γ-irradiation at a dose of 4 Gy (p=0.047 in comparison with the control). However, no significant changes were found in the relative number of cancer stem cells and the expression level of OCT4, NANOG, and SOX2 genes after neutron, proton beam irradiation or their combined action at a total equieffective dose of 4 Gy in comparison with the control in both cell lines. The absolute number of cancer stem cells decreased under the influence of neutron or proton radiation in comparison with the control (p<0.05 for both cell lines). At the same time, the effects of sequential exposures to neutron and proton radiation on the size of the cancer stem cell pool depended on the molecular subtype of cancer cells. Additive interaction was observed for MCF-7 line and antagonistic one for MDA-MB-231 line (coefficients of synergism were 0.96 and 0.45, respectively).


Asunto(s)
Neoplasias de la Mama , Protones , Humanos , Femenino , Neoplasias de la Mama/genética , Neoplasias de la Mama/radioterapia , Neoplasias de la Mama/metabolismo , Células Madre Neoplásicas/metabolismo , Células MCF-7 , Neutrones , Línea Celular Tumoral
3.
Bull Exp Biol Med ; 170(2): 241-245, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33263849

RESUMEN

The proportion of CD44+CD24low cancer stem cells (CSC) was determined in cervical scrapings of 41 patients with squamous cell carcinoma of the uterine cervix before treatment and after irradiation in a total focal dose of 10 Gy. The relationship of quantitative changes in the CSC population with such parameters of papillomavirus infection as genotype, viral load, and physical status of HPV DNA (the absence or presence of HPV DNA integration into the cell genome and the degree of integration) was studied. Single- and multi-factor analysis revealed 2 independent indicators affecting the radiation response of CSC: initial number of these cells before treatment and physical status of HPV DNA. The increase in the CSC proportion after radiation exposure was observed 4.5-fold more often in patients with an initially low proportion of CSC (<3%) than that in other patients (p=0.001). The CSC proportion increased by on average 3% after irradiation in patients with complete integration of HPV 16/18 DNA and decreased by 3.8 % in patients with partial integration or no integration (p=0.03).


Asunto(s)
Carcinoma de Células Escamosas/radioterapia , Células Madre Neoplásicas/efectos de la radiación , Neoplasias del Cuello Uterino/radioterapia , Adulto , Anciano , Alphapapillomavirus , Antígeno CD24/biosíntesis , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/virología , Cuello del Útero/virología , ADN Viral/metabolismo , Femenino , Genotipo , Papillomavirus Humano 16/genética , Papillomavirus Humano 18/genética , Humanos , Receptores de Hialuranos/biosíntesis , Persona de Mediana Edad , Biología Molecular , Infecciones por Papillomavirus/complicaciones , Infecciones por Papillomavirus/genética , Tolerancia a Radiación , Resultado del Tratamiento , Neoplasias del Cuello Uterino/genética , Neoplasias del Cuello Uterino/virología , Carga Viral , Integración Viral , Adulto Joven
4.
Bull Exp Biol Med ; 168(1): 156-159, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31773353

RESUMEN

Prognostic significance of the proportion of cancer stem cells in cervical scrapings from 38 patients with uterine cervical cancer before treatment and after irradiation in a total dose of 10 Gy was assessed for immediate results of radio- and combined chemoradiotherapy evaluated by the degree of tumor regression in 3-6 months after the treatment. Cancer stem cells were detected as cells with CD44+CD24low immunophenotype by flow cytometry. The proportion of cancer stem cells in patients with the complete tumor regression decreased by on average 2.2±1.1% after irradiation, while in patients with partial regression this indicator increased by on average 3.3±2.3% (p=0.03). Multiple regression analysis revealed two independent indicators affecting tumor regression: the stage of the disease (which is quite expected) and change in the proportion of cancer stem cells after the first irradiation sessions (R=0.60, p<0.002 for the model in the whole). The proportion of cancer stem cells before the treatment did not have prognostic significance.


Asunto(s)
Células Madre Neoplásicas/efectos de la radiación , Neoplasias del Cuello Uterino/patología , Neoplasias del Cuello Uterino/radioterapia , Femenino , Citometría de Flujo , Humanos , Receptores de Hialuranos/metabolismo , Inmunofenotipificación , Pronóstico , Análisis de Regresión , Neoplasias del Cuello Uterino/metabolismo
5.
Bull Exp Biol Med ; 168(1): 87-91, 2019 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-31768781

RESUMEN

The presence of virus DNA integration into the cell genome was studied for 47 primary HPV16-positive patients with morphologically verified stage III cervical cancer. By using ROC analysis, the patients were divided into two groups: with and without HPV DNA integration into the host cell genome. The differences between the groups by the histological type, degree of tumor differentiation, and primary response to therapy were statistically insignificant. Virus DNA integration more than 7-fold reduced 5-year relapse-free survival and 1.7-fold reduced overall survival rate in comparison with patients without HPV DNA integration (p=0.0002 and p=0.05, respectively). The relative risk of adverse outcome of the disease in patients with the presence of HPV16 DNA integration increases by 4 times over a period of less than 3 years (р=0.0006) at high AUC level. The probability of earlier progression of the disease in patients with of HPV DNA integration calculated according to the Cox proportional hazards model was 85.5% (hazard ratio 5.96; p=0.002). Thus, the results suggest that the presence of HPV16 DNA integration into the cell genome is an independent factor in predicting clinical outcome of advanced cervical cancer and can serve as an effective criterion for the individual choice of treatment tactics for the patients.


Asunto(s)
ADN Viral/genética , Papillomaviridae/genética , Papillomaviridae/patogenicidad , Infecciones por Papillomavirus/genética , Neoplasias del Cuello Uterino/patología , Femenino , Humanos , Recurrencia Local de Neoplasia/genética , Pronóstico , Modelos de Riesgos Proporcionales , Neoplasias del Cuello Uterino/genética , Neoplasias del Cuello Uterino/virología , Integración Viral/genética , Integración Viral/fisiología
6.
Radiats Biol Radioecol ; 56(3): 285-292, 2016 05.
Artículo en Ruso | MEDLINE | ID: mdl-30629875

RESUMEN

The aim of this study is to assess the level of somatic mutagenesis according to the frequency of lymphocytes bearing mutations at the locus of T-cell receptor (TCR) in the residents of the Bryansk region contaminated with radionuclides as a result of the Chernobyl accident. The study was :conducted in 2014 in two regional centers - Klintsy and Novozybkov (average¹³7Cs pollution density of 322 and 708 kBq/m²,.respectively). The average frequency of the TCR-mutant cells in the total group of examined residents of the Bryansk region (n = 237) was not significantly different from that in the group of agematched control persons living in un- contaminated areas (n = 146): 3.8 x 10⁻4 vs 3.5 x 10⁻4, respectively (p = 0.84). However, after separation of examinees into 3 groups depending on age at the start of irradiation (at.the moment of the Chernobyl acci- dent) it was found that the average frequency of the TCR-mutant cells in the persons exposed in utero was 1.6 higher than that in the control group (p = 0.04). Proportion of persons with an increased frequency of the mutant cells (more than the age norm of this indicator) among prenatally exposed population reached 23.8%; which was about.4 times higher than in the control group (p = 0.04). Proportion of persons with an increased frequency of the TCR-mutant cells in group "0-17 years at the start of irradiation", was about 2 times higher than in controls, but this difference was not statistically significant (8.0% vs 4.3%, respectively, p = 0.33). In the third group "18 or more years old at the start of irradiation" we could not register the difference in the average frequency of theTCR mutant cells or the proportion of persons with an increased frequency of these cells in comparison with the age-matched control group. In general, comparison with earlier data shows that age-related regularities of somatic mutagenesis established 15-18 years after the Chernobyl accident persist at a later date (after 28 years in this study).


Asunto(s)
Accidente Nuclear de Chernóbil , Linfocitos/efectos de la radiación , Mutagénesis/efectos de la radiación , Receptores de Antígenos de Linfocitos T/genética , Adolescente , Adulto , Anciano , Radioisótopos de Cesio/toxicidad , Aberraciones Cromosómicas/efectos de la radiación , Femenino , Humanos , Persona de Mediana Edad , Mutación/efectos de la radiación , Liberación de Radiactividad Peligrosa , Contaminantes Radiactivos/toxicidad , Receptores de Antígenos de Linfocitos T/efectos de la radiación , Adulto Joven
7.
Vopr Onkol ; 62(5): 660-665, 2016.
Artículo en Ruso | MEDLINE | ID: mdl-30695594

RESUMEN

Accumulation of doxorubicin (Dox), its conjugates with the second generation dendritic polymer (G2-Dox) and vector pro- tein (recombinant third domain of alpha-fetoprotein - 3D-G2- Dox) in normal and tumor cells was studied in vitro within the framework of the development of selective transport system of anticancer drugs to the target cells. The objects of the study were cells of peripheral blood mononuclear fraction of healthy donors and cells of breast adenocarcinoma lines MCF-7 and MCF-7/MDR1, differing in chemosensitivity. G2-Dox and 3D-G2-Dox accumulated in tumor cells of the both lines better than free Dox (p<0,05). However removal of these drugs out of cells MCF-7 and MCF-7/MDR1 was significantly different: in the latter case all free Dox was excluded from the cells for 24 hours while Dox, accumulated in composition with dendrimers, still remained in the cells. It was important that 3D-G2-Dox (unlike the G2-Dox) accumulated in normal cells worse than free Dox (p<0.01). Thus, the results indicate that the use of 3D-G2-Dox is the most promising because it accumulates in tumor cells better and in normal cells worse than free Dox. Furthermore it can be assumed that the use of 3D-G2-Dox would be especially useful in cases of multi-drug resistance associated with the high expression of P-glycoprotein.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Neoplasias de la Mama/tratamiento farmacológico , Dendrímeros , Doxorrubicina , Portadores de Fármacos , alfa-Fetoproteínas , Subfamilia B de Transportador de Casetes de Unión a ATP/biosíntesis , Adenocarcinoma/metabolismo , Adenocarcinoma/patología , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Dendrímeros/química , Dendrímeros/farmacocinética , Dendrímeros/farmacología , Doxorrubicina/química , Doxorrubicina/farmacocinética , Doxorrubicina/farmacología , Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Portadores de Fármacos/farmacología , Femenino , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Células MCF-7 , Proteínas de Neoplasias/biosíntesis , alfa-Fetoproteínas/química , alfa-Fetoproteínas/farmacocinética , alfa-Fetoproteínas/farmacología
8.
Radiats Biol Radioecol ; 56(4): 382-388, 2016 Jul.
Artículo en Inglés, Ruso | MEDLINE | ID: mdl-30703297

RESUMEN

As previously indicated, side population cells (side population, SP) of breast cancer line MCF-7 have greater resistance to the action of low-LET radiation compared to other tumor cells (non SP, NSP). One can assume that one possible reason for the high radioresistance of this fraction of tumor cells is the increased expression of different heat shock proteins (HSP) before and/or after radiation exposure. To verify this hypothesis, we investigated the expression of HSP27 and HSP70 in these populations of cells-before and after irradiation at a dose of 5.0 Gy. The study was performed using scanning microscopy for NSP and SP cells after sorting and immunocytochemical staining. A substantial increase of HSP27 and HSP70 in SP cells was found after irra- diation as'compared with the control. In NSP cells the HSP27 level increased in response to radiation exposure, but to a lesser extent than in SP cells, while the content of HSP70 did not change after irradiation. The results confirm the assumption about HSP27 and HSP70 participation in the formation of SP cell radioresistance by the example of MCF-7 line.


Asunto(s)
Neoplasias de la Mama/genética , Proteínas de Choque Térmico HSP27/genética , Proteínas HSP70 de Choque Térmico/genética , Tolerancia a Radiación/genética , Apoptosis , Neoplasias de la Mama/patología , Neoplasias de la Mama/radioterapia , Femenino , Regulación Neoplásica de la Expresión Génica , Humanos , Células MCF-7 , Radiación
9.
Radiats Biol Radioecol ; 56(5): 487-493, 2016 Sep.
Artículo en Inglés, Ruso | MEDLINE | ID: mdl-30703308

RESUMEN

The quantitative regularities of changes of cancer stem cell (CSC) population were explored after local γ-irradiation of experimental tumors (murine melanoma line B16). CSCs were detected by the ability of these cells to exclude Hoechst 33342 fluorescent dye and to form a so-called side population (SP) under flow cytometry study. In the control group of unexposed mice a positive correlation was found between the proportion of CSCs (SP) and tumorweight at the initial stage of growth (R = 0.77, p = 0.009). In the advanced stages of tumor growth similar relationship was not revealed. Statistically significant increase in the proportion of CSCs (SP) occurred 2-5 days after exposure of tumor to a dose of 10 Gy as compared to control; this index returned to the control level 8 days after irradiation. On the second day after exposure to radiation a linear correlation between the percentage of CSCs and a radiation dose in the range of 2-10 Gy was established (R = 0.98, p = 0.003), confirming a higher radioresistance of this population as compared to other cells not only in vitro (as it was previously shown by us and other authors), but also in vivo. These results suggest the possibility of application of this model system to assess the CSC sensitivity to various antitumor agents in vivo, including preclinical trials, and clarify the details of the practical application of this method.


Asunto(s)
Melanoma Experimental/radioterapia , Células Madre Neoplásicas/efectos de la radiación , Exposición a la Radiación , Tolerancia a Radiación/genética , Animales , Bencimidazoles , Línea Celular Tumoral , Citometría de Flujo , Rayos gamma/efectos adversos , Humanos , Melanoma Experimental/patología , Ratones , Tolerancia a Radiación/efectos de la radiación , Células de Población Lateral/efectos de la radiación
10.
Radiats Biol Radioecol ; 55(6): 591-7, 2015.
Artículo en Ruso | MEDLINE | ID: mdl-26964344

RESUMEN

The dendritic polymers (dendrimers) are perspective nanocontainers for transportation of anticancer drugs into cells and a controlled release of the delivered substances. However, the combined effect of ionizing radiation and dendrimers loaded with anticancer drugs has been poorly studied and is the aim of this research. We used poliamidoamin (PAMAM) dendrimers of the second generation (G2) covalently conjugated with doxorubicin (Dox) via an acid labile linker, cis-aconitic anhydride. We compared the intracellular accumulation of Dox and growth rate of the MCF-7 cell culture under the single and combined action of ionizing radiation at a dose of 4 Gy, free Dox and G2-Dox. It was found that within 2 hours free Dox accumulated in cancer cells better than Dox connected with G2 dendrimers (p < 0.05 in the concentration range of 1-5 µmol/l). The intracellular accumulation of Dox was higher by 1.7 times for the free Dox than that connected with dendrimers (for concentration 0.5 µmol/l p = 0.02) after 26 hours of incubation. Like the intracellular accumulation of Dox, inhibition of the cell culture growth was more pronounced when using free Dox than G2-Dox in the case of both a single and combined action of these drugs. Subadditivity effects of the combined action of both drugs and ionizing radiation are shown in terms of reducing the number of tumor cells 24 hours after irradiation. The results indicate the need for further development of selective delivery systems for Doxin tumor cells, providing a more intense accumulation of anticancer drug in target cells.


Asunto(s)
Antibióticos Antineoplásicos/farmacología , Proliferación Celular , Dendrímeros/química , Doxorrubicina/farmacología , Portadores de Fármacos/química , Endocitosis , Radiación Ionizante , Antibióticos Antineoplásicos/administración & dosificación , Antibióticos Antineoplásicos/farmacocinética , Técnicas de Cultivo de Célula , Proliferación Celular/efectos de los fármacos , Proliferación Celular/efectos de la radiación , Relación Dosis-Respuesta a Droga , Doxorrubicina/administración & dosificación , Doxorrubicina/farmacocinética , Endocitosis/efectos de los fármacos , Endocitosis/efectos de la radiación , Fase G2/efectos de los fármacos , Fase G2/efectos de la radiación , Humanos , Células MCF-7
12.
Vopr Onkol ; 60(4): 497-503, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-25552072

RESUMEN

The objective of this study was to improve the immediate and long-term results of combined treatment of patients with locally advanced rectal cancer. The study included 128 patients with morphologically confirmed diagnosis and clinical stage cT3/T4 and N-/N+, treated from 1998 to 2009. The comparison group had 64 patients, combined treatment included prolonged preoperative radiotherapy 4 Gy and 40 Gy, surgery was performed after 4 weeks. In the study group--also 64 patients--combined treatment consisted of preoperative chemoradiotherapy (continuous a-120 hour infusion of 5-fluorouracil at a dose of 500 mg/m2 in the first and last week of radiotherapy in 2 Gy to 50 Gy), surgery was performed through 6 weeks after chemoradiotherapy. Excision of the primary tumor was performed in 40 (62.5%) patients in the control group and in 53 (82.8%) patients in the study group. Wherein R-0 resections were performed in 32 (67%) patients and in 41 (73%), and R-1 resections--in 1 (2%) patients, and 7 (13%) patients in the control and study groups respectively. A 5-year survival rate was 43.6 ± 7.2% control and 62.7 ± 5.1 % in the study group.


Asunto(s)
Adenocarcinoma/patología , Adenocarcinoma/terapia , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Quimioradioterapia Adyuvante , Terapia Neoadyuvante/métodos , Neoplasias del Recto/patología , Neoplasias del Recto/terapia , Adenocarcinoma/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Esquema de Medicación , Femenino , Fluorouracilo/administración & dosificación , Estudios de Seguimiento , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Terapia Neoadyuvante/efectos adversos , Estadificación de Neoplasias , Neoplasias del Recto/cirugía , Análisis de Supervivencia , Factores de Tiempo , Resultado del Tratamiento
13.
Radiats Biol Radioecol ; 54(2): 153-61, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-25764816

RESUMEN

The aim of the study was to investigate the effects of chronic exposure to ionizing radiation on the cellular immunity of employees of the nuclear industry. Peripheral blood samples were studied in 195 employees of Physics and Power Engineering Institute (PPEI, Obninsk), who professionallycontacted with sources ofionizing radiation and were under individual dosimetric control. The median cumulative dose was 61.2 mSv, the average duration of work at the enterprise -27 ± 5 years. The control group consisted of 57 healthy individuals of a similar age and sex who did not have contact with sources of radiation. Indicators of the cellular immunity were determined by flow cytometry. Comparison of a cell-mediated immunity was conducted separately in the two age groups (20-40 and 41-70 years). The significant reduction inthe relative content of CD4+CD8 T-helper cells and the increase in the relative content of CD3-CD16, CD56+ NK-cells were found in both age groups of the PPEI employees in comparison with the age-matched control groups (p < 0.05). Separate analysis of the results in the low dose group (up to 50 mSv) demonstrated reducing the relative content of T-helper cells and increasing the proportion of NK-cells (as in the analysis of whole groups without taking into account the cumulative dose), as well as reducing the proportion of CD8+CD25+ activated lymphocytes in PPEI employees as compared to the age-matched control. Multiple regression analysis of the immunological parameters dependence on age and dose established a significant correlation of the relative content of CD3-CD19+ B-cells (r = -0.284, p = 2.9 x 10(-4)) and CD19+CD5+ B1-lymphocytes (r = -0.241, p = 0.002) with the dose of employees regardless of age, indicating the relationship of the changes in the B-cell component of immune system with the radiation factor.


Asunto(s)
Inmunidad Celular/efectos de la radiación , Células Asesinas Naturales/efectos de la radiación , Subgrupos Linfocitarios/efectos de la radiación , Linfocitos T/efectos de la radiación , Adulto , Anciano , Antígenos CD/inmunología , Antígenos CD/efectos de la radiación , Femenino , Citometría de Flujo , Humanos , Masculino , Persona de Mediana Edad , Plantas de Energía Nuclear , Radiación Ionizante
14.
Radiats Biol Radioecol ; 54(3): 256-64, 2014.
Artículo en Ruso | MEDLINE | ID: mdl-25764829

RESUMEN

Radioresistance of cancer stem cells (CSCs) is regarded as one of the possible causes of cancer recurrence after radiotherapy. Since the regularities and mechanisms of radiation effects on this population of cells have not been sufficiently studied, the aim of this work is to elucidate the changes in the CSC number after γ-irradiation in stable cultures of tumor cells in vitro and tumor tissue in vivo (in the course of radiation therapy of patients with cancers of the upper respiratory tract). CSCs were identified in the cell lines B16, MCF-7, HeLa by the ability to exclude the fluorescent dye Hoechst 33342 (SP method) 48-72 h after irradiation at the doses of 1-20 Gy and in biopsy material by immunophenotype CD44+CD24(-/low) before and 24 h after irradiation at the total dose of 10 Gy. The essential differences in the response of CSCs and other cancer cells were found after exposure to low-LET radiation. The absolute number of CSCs increased after a single exposure at the doses ranging from 1 to 5-10 Gy in different cell cultures, but a further dose increase maintained the current number of CSCs or decreased it. At the same time, the number of non CSCs significantly decreased with increasing doses of radiation exposure, as expected. Fractionated irradiation in vivo at a total dose of 10 Gy increased the relative amount of CSCs in most patients. The registered changes are an integral indicator of cell death, cell division delay immediately after irradiation, proliferation at a later time, possible dedifferentiation of non CSCs, etc. The exact contribution of each of them to the radiation-induced increase of the CSCs number is of considerable interest and requires further research.


Asunto(s)
Rayos gamma , Neoplasias Laríngeas/radioterapia , Células Madre Neoplásicas/efectos de la radiación , Tolerancia a Radiación/genética , Adulto , Anciano , Animales , Femenino , Células HeLa/efectos de la radiación , Humanos , Receptores de Hialuranos/genética , Receptores de Hialuranos/inmunología , Inmunofenotipificación , Neoplasias Laríngeas/patología , Células MCF-7/efectos de la radiación , Masculino , Ratones , Persona de Mediana Edad , Células Madre Neoplásicas/patología , Células Madre Neoplásicas/ultraestructura
15.
Radiats Biol Radioecol ; 53(6): 604-11, 2013.
Artículo en Ruso | MEDLINE | ID: mdl-25486743

RESUMEN

The aim of this investigation is to study the number of circulating tumor cells (CTCs) in the blood of cancer patients after systemic photodynamic therapy (PDT) at different times and to assess apoptosis of these cells. The study group consisted of 19 patients with malignant tumors of epithelial origin at various stages (II-IV). CTC identification was performed with flow cytometry by immunophenotype Ep-CAM (CD326)+ CD45-. CTC apoptosis was identified by criteria of plasma membrane integrity and phosphatidylserine translocation on the outer surface of the membrane. Negative correlation between the CTC frequency and apoptotic death rate of these cells was found in patients before the treatment (R = -0.51, p = 0.03). CTC frequency gradually reduced during the first three days after PDT, and then it was maintained at the same level until the end of the follow-up (7 days). At the individual level, the effect of PDT depended on the frequency of CTCs before the treatment: the decrease in these cell frequency occurred significantly more often in the patients with an initially high frequency of CTCs than in other patients (p = 0.05). With the decrease in the CTC frequency, apoptotic death increased within 6 hours after the treatment and remained at the same level until the end of the follow-up period. The results demonstrate the efficacy of systemic PDT for elimination of tumor cells circulating in the peripheral blood of cancer patients with different localization of primary tumor and stage of disease.


Asunto(s)
Neoplasias de la Mama/terapia , Neoplasias Pulmonares/terapia , Células Neoplásicas Circulantes/efectos de la radiación , Fotoquimioterapia , Adulto , Anciano , Apoptosis/efectos de la radiación , Neoplasias de la Mama/patología , Recuento de Células , Femenino , Citometría de Flujo , Humanos , Neoplasias Pulmonares/patología , Masculino , Persona de Mediana Edad
16.
Tsitologiia ; 55(8): 553-9, 2013.
Artículo en Ruso | MEDLINE | ID: mdl-25486787

RESUMEN

As it was shown by us earlier, side population (SP) cells are more resistant to the low-LET radiation than the other part of mouse melanoma B16 cells (Matchuk et al., 2012). The aim of our research was finding some mechanisms of radioresistance, therefore we analyzed SP and nonSP cell cycle distribution, spontaneous and radiation induced DNA double-strand breaks (number of γH2AX foci) and intracellular NO concentration. The results indicate that SP cells have significantly less DNA double-strand breaks after irradiation at dose of 3 Gy than nonSP cells (24.4 vs 40.3, accordingly, P < 0.05 Mann-Whitney Ucriterion). SP cells are more quiescent compared to nonSP G1/G0 fraction is 85 vs 39%, accordingly, P < 0.01 Mann-Whitney U criterion). Most nonSP cells reside in S, G2/M phases (61%), believed to be rather radiosensitive. Thus, the difference of SP and nonSP cells radiosensitivity can be partly explained by peculiarities of cell cycle distribution. NO concentration is 1.5 times higher in SP than nonSP cells (P < 0.05 Mann-Whitney U criterion); since it is known that NO inhibits apoptosis, being one of the mechanisms of genetic stability maintenance, greater number of spontaneous DNA double-strand breaks in SP cells is unsurprising (P < 0.05 Mann-Whitney U criterion). The above-listed results explain considerably the higher resistance of SP cells to the action of low-LET radiation in comparison with other melanoma B16 cells. Further study of this question can become the basis for development of tools to target SP cells and, ultimately, more effective cancer treatment.


Asunto(s)
Roturas del ADN de Doble Cadena/efectos de la radiación , Melanoma Experimental/genética , Tolerancia a Radiación/genética , Células de Población Lateral/efectos de la radiación , Animales , Apoptosis/genética , Apoptosis/efectos de la radiación , Supervivencia Celular/efectos de la radiación , Puntos de Control de la Fase G2 del Ciclo Celular/genética , Puntos de Control de la Fase G2 del Ciclo Celular/efectos de la radiación , Expresión Génica , Histonas/genética , Histonas/metabolismo , Melanoma Experimental/metabolismo , Melanoma Experimental/patología , Ratones , Óxido Nítrico/biosíntesis , Puntos de Control de la Fase S del Ciclo Celular/genética , Puntos de Control de la Fase S del Ciclo Celular/efectos de la radiación , Células de Población Lateral/metabolismo , Células de Población Lateral/patología , Células Tumorales Cultivadas
17.
Vopr Onkol ; 59(6): 756-60, 2013.
Artículo en Ruso | MEDLINE | ID: mdl-24624787

RESUMEN

For the 83 patients with HPV 16-cancer of the cervix (cervical cancer) I-III stages it was performed a comparative analysis of primary tumor response to therapy, the clinical outcome of the disease for 3-5 years after radical treatment and an evaluation of the possible contribution in these rates of the physical status of the virus. It was shown that total tumors regression in the early stages of the observation predominate in patients with "high-integrated" virus DNA (the degree of integration > 50%) of compared with a group of patients with episomal and "low-integrated" form of the virus, but in a distant periods (3-5 years) in the first group predominate an adverse outcome of disease. This pattern is true for tumors of stage I-III, and for less common--I-II stages. It is assumed that the integration of HPV16 DNA into the cellular genome may serve as an independent predictor of clinical outcome of cervical cancer.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Quimioradioterapia , Genoma Humano , Papillomavirus Humano 16/patogenicidad , Infecciones por Papillomavirus/complicaciones , Neoplasias del Cuello Uterino/patología , Neoplasias del Cuello Uterino/terapia , Adulto , Anciano , Investigación sobre la Eficacia Comparativa , ADN Viral/análisis , Supervivencia sin Enfermedad , Femenino , Fluorouracilo/administración & dosificación , Papillomavirus Humano 16/genética , Humanos , Persona de Mediana Edad , Invasividad Neoplásica , Estadificación de Neoplasias , Infecciones por Papillomavirus/virología , Compuestos de Platino/administración & dosificación , Reacción en Cadena de la Polimerasa , Valor Predictivo de las Pruebas , Pronóstico , Resultado del Tratamiento , Neoplasias del Cuello Uterino/diagnóstico , Neoplasias del Cuello Uterino/virología
18.
Radiats Biol Radioecol ; 52(3): 261-7, 2012.
Artículo en Ruso | MEDLINE | ID: mdl-22891549

RESUMEN

Cancer stem cells (CSC) found in multiple tumor types and cancer cell lines were shown to be more resistant to low-LET radiation in comparison to other cancer cells. Therefore, CSC are supposed to determine the long-term effect of cancer therapy. Research into the CSC sensitivity to high-LET radiation is of great interest because of the advances in hadron therapy. The aim of this investigation is to compare CSC and other cancer cell sensitivity to the low- (60Co gamma-rays) and high-LET (neutron) radiation. To identify CSC, we used the low cytometry-based side population (SP) technique based on the CSC capacity to produce the efflux of the vital dye Hoechst 33342. SP and non SP cells were sorted and exposed to gamma and neutron radiation at doses of 1-10 Gy and 0.1-4.7 Gy, correspondingly. We applied the colony-formation test to examine the SP and non SP survival rate after irradiation. It was shown that the sensitivity of SP to gamma-irradiation was lower than that of other cells: D0 average values (+/- SE) made up 2.3 +/- 0.3 Gy and 1.4 +/- 0.2 Gy, correspondingly (p = 0.047). The survival rate of SP and non SP did not differ after neutron irradiation. The values of relative biological effectiveness of neutron radiation relative to gamma-radiation at the D10 level were 2.6 for SP and 2.1 for other cells. The obtained results justify for the first time a high efficiency of application of neutrons in radiotherapy from the point of view of CSC elimination.


Asunto(s)
Neutrones Rápidos , Rayos gamma , Melanoma Experimental/patología , Células Madre Neoplásicas/efectos de la radiación , Animales , Técnicas de Cultivo de Célula , Ciclo Celular/efectos de la radiación , Línea Celular Tumoral , Supervivencia Celular/efectos de la radiación , Relación Dosis-Respuesta en la Radiación , Citometría de Flujo , Ratones , Efectividad Biológica Relativa
19.
Radiat Prot Dosimetry ; 151(4): 666-70, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22908345

RESUMEN

The paper discusses technology for establishing potential cancer risk groups, based on methods of molecular and radiation epidemiology. Assay of gene mutations at the T-cell receptor (TCR) locus as the method of molecular epidemiology was used for measuring the frequency of TCR-mutations in 320 nuclear workers of the Institute of Physics and Power Engineering (IPPE). The method of radiation epidemiology was applied to the estimation of attributable risk fraction (ARF) for solid cancers in these groups. The main estimates of radiation risk after the Chernobyl accident are in close agreement with the International Commission on Radiological Protection (ICRP) Publication, 103 models published in 2007. In nuclear workers of the IPPE with ARF ≥ 10%, the increased level of TCR-mutations occurs more often (risk ratio=9.7; 95% CI: 2.9; 32.1).


Asunto(s)
Neoplasias , Protección Radiológica , Accidente Nuclear de Chernóbil , Humanos , Modelos Teóricos , Neoplasias Inducidas por Radiación/epidemiología , Dosis de Radiación , Factores de Riesgo
20.
Gig Sanit ; (5): 23-6, 2011.
Artículo en Ruso | MEDLINE | ID: mdl-22184995

RESUMEN

The paper presents the results of an association study of a predisposition to increased somatic mutagenesis detected by the test for TCR-mutant lymphocytes (CD3-CD4+ phenotype). A study group consisted of 251 women who lived in the towns polluted by radionuclides after the Chernobyl accident and had estrogen-dependent reproductive system diseases (uterine myoma, fibrocystic mastopathy). The carriage of minor alleles in the genes (CYP1A1, GSTM1, and ABCB1) of all three stages of detoxification of xenobiotics was associated with the rise in the spontaneous frequency of TCR-mutant cells. Overweight modified the genotype (at CYP1A1 and GSTT1 loci) - environment interaction. When background radiation became higher, the contribution of minor alleles in the CYP1A1 genes to the instability recorded as the elevated frequency of TCR-mutant cells increased.


Asunto(s)
Accidente Nuclear de Chernóbil , Enfermedad Fibroquística de la Mama/genética , Leiomioma/genética , Linfocitos/efectos de la radiación , Polimorfismo de Nucleótido Simple , Contaminantes Radiactivos , Receptores de Antígenos de Linfocitos T/genética , Neoplasias Uterinas/genética , Subfamilia B de Transportador de Casetes de Unión a ATP , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/genética , Adulto , Citocromo P-450 CYP1A1/genética , ADN Glicosilasas/genética , Femenino , Enfermedad Fibroquística de la Mama/sangre , Frecuencia de los Genes , Estudios de Asociación Genética , Genotipo , Glutatión Transferasa/genética , Humanos , Leiomioma/sangre , Recuento de Linfocitos , Linfocitos/citología , Linfocitos/inmunología , Mutación , Federación de Rusia , Ucrania , Neoplasias Uterinas/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...